European urologyPub Date : 2025-07-26DOI: 10.1016/j.eururo.2025.06.022
Zuomin Wang, Wangdong Deng, Zhigang Zhao
{"title":"Re: Marcio Covas Moschovas, Shady Saikali, Marco Sandri, et al. Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robotic Urology Section Scientific Working Group. Eur Urol 2025;88:103–13","authors":"Zuomin Wang, Wangdong Deng, Zhigang Zhao","doi":"10.1016/j.eururo.2025.06.022","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.06.022","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"2 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144710915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-07-25DOI: 10.1016/j.eururo.2025.07.009
Pietro Scilipoti, Mattia Longoni, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, Alberto Briganti, Francesco Montorsi
{"title":"Re: Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics","authors":"Pietro Scilipoti, Mattia Longoni, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, Alberto Briganti, Francesco Montorsi","doi":"10.1016/j.eururo.2025.07.009","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.07.009","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"56 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144710923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-07-25DOI: 10.1016/j.eururo.2025.06.024
Roderick C.N. van den Bergh, Henk G. van der Poel, Pim J. van Leeuwen, Robert J. van Soest
{"title":"Re: Effect of NeuroSAFE-guided RARP Versus Standard RARP on Erectile Function and Urinary Continence in Patients with Localised Prostate Cancer (NeuroSAFE PROOF): A Multicentre, Patient-blinded, Randomised, Controlled Phase 3 Trial","authors":"Roderick C.N. van den Bergh, Henk G. van der Poel, Pim J. van Leeuwen, Robert J. van Soest","doi":"10.1016/j.eururo.2025.06.024","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.06.024","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"26 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144710920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-07-25DOI: 10.1016/j.eururo.2025.06.027
José David Cardona Ortegón, Javier Alejandro Lamprea Ardila, Gustavo Adolfo Triana Rodriguez
{"title":"Re: Paolo Capogrosso, Maarten Albersen, Arthur L. Burnett, et al. Erectile Dysfunction: Update on Clinical Management. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.05.004","authors":"José David Cardona Ortegón, Javier Alejandro Lamprea Ardila, Gustavo Adolfo Triana Rodriguez","doi":"10.1016/j.eururo.2025.06.027","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.06.027","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"34 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144710916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-07-25DOI: 10.1016/j.eururo.2025.06.026
Peter Albers
{"title":"Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial","authors":"Peter Albers","doi":"10.1016/j.eururo.2025.06.026","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.06.026","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"26 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144710917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-07-24DOI: 10.1016/j.eururo.2025.05.019
Martin H. Voss, Howard Gurney, Vagif Atduev, Cristina Suarez, Miguel A. Climent, David Pook, Piotr Tomczak, Philippe Barthélémy, Jae Lyun Lee, Taron Nalbandian, Viktor Stus, Thomas Ferguson, Pawel Wiechno, Erhan Gokmen, Louis Lacombe, Craig Gedye, Jerry Cornell, Manish Sharma, Joseph E. Burgents, Laurence Albiges
{"title":"First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial","authors":"Martin H. Voss, Howard Gurney, Vagif Atduev, Cristina Suarez, Miguel A. Climent, David Pook, Piotr Tomczak, Philippe Barthélémy, Jae Lyun Lee, Taron Nalbandian, Viktor Stus, Thomas Ferguson, Pawel Wiechno, Erhan Gokmen, Louis Lacombe, Craig Gedye, Jerry Cornell, Manish Sharma, Joseph E. Burgents, Laurence Albiges","doi":"10.1016/j.eururo.2025.05.019","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.05.019","url":null,"abstract":"<h3>Background and objective</h3>Initial results from the KEYNOTE-B61 trial demonstrated that pembrolizumab combined with lenvatinib has promising antitumor activity in previously untreated advanced non–clear-cell renal cell carcinoma (nccRCC). We report updated efficacy and safety results after nearly 2 yr of follow-up.<h3>Methods</h3>The single-arm, multicenter, phase 2 KEYNOTE-B61 trial enrolled patients aged ≥18 yr with previously untreated advanced nccRCC. All participants received pembrolizumab 400 mg intravenously every 6 wk (up to 18 cycles, approx. 2 yr) plus lenvatinib 20 mg orally once daily. The primary endpoint was the objective response rate (ORR) according to Response Evaluation Criteria in Solid Tumors v1.1 as assessed on blinded independent central review. Duration of response (DOR) and safety were secondary endpoints.<h3>Key findings and limitations</h3>A total of 158 patients received at least one dose of study treatment. Median follow-up was 22.8 mo (range 16.6–27.6). The ORR was 51% (95% confidence interval 43–59); 13 patients (8.2%) had a confirmed complete response and 67 (42%) had a confirmed partial response. In the subgroup with a confirmed response, median DOR was 19.5 mo (range 1.5+ to 23.5+). ORR was generally consistent across subgroups, including histologic subtypes (34–67%) and the presence of sarcomatoid features (47%). Grade 3 or 4 treatment-related adverse events were reported for 92 patients (58%). No deaths due to treatment-related adverse events occurred.<h3>Conclusion and clinical implications</h3>After approximately 2 yr of follow-up, pembrolizumab plus lenvatinib showed durable antitumor activity in KEYNOTE-B61, with no new safety signals. These results support pembrolizumab + lenvatinib as a first-line treatment option for advanced nccRCC.","PeriodicalId":12223,"journal":{"name":"European urology","volume":"23 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144694046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-07-23DOI: 10.1016/j.eururo.2025.06.020
{"title":"Platinum Hall of Fame","authors":"","doi":"10.1016/j.eururo.2025.06.020","DOIUrl":"10.1016/j.eururo.2025.06.020","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"88 2","pages":"Pages e23-e34"},"PeriodicalIF":25.3,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144684733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-07-19DOI: 10.1016/j.eururo.2025.06.018
Bhaskar K. Somani, Jens Rassweiler, Evangelos Liatsikos, Alexandre Mottrie, Thomas Knoll, Jens Bedke, Giampaolo Bianchi, Kemal Sarica, Alberto Briganti, Ton Brouwers, Alberto Breda
{"title":"European Association of Urology Policy on Telesurgery","authors":"Bhaskar K. Somani, Jens Rassweiler, Evangelos Liatsikos, Alexandre Mottrie, Thomas Knoll, Jens Bedke, Giampaolo Bianchi, Kemal Sarica, Alberto Briganti, Ton Brouwers, Alberto Breda","doi":"10.1016/j.eururo.2025.06.018","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.06.018","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"5 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144665085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}